Phase I/II study of biweekly nab‐paclitaxel in patients with platinum‐pretreated non‐small cell lung cancer: NJLCG1402

BACKGROUND: NJLCG1402 was a phase I/II trial investigating biweekly nanoparticle albumin‐bound paclitaxel (nab‐PTX) in patients with advanced non‐small cell lung cancer (NSCLC). METHODS: The study included patients aged ≥20 years with previously treated NSCLC. Nab‐PTX (100–150 mg/m(2)) was administe...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyauchi, Eisaku, Tanaka, Hisashi, Nakamura, Atsushi, Harada, Toshiyuki, Nakagawa, Taku, Morita, Mami, Jingu, Daisuke, Kuda, Tomoya, Gamou, Shunichi, Saito, Ryota, Inoue, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563146/
https://www.ncbi.nlm.nih.gov/pubmed/34523232
http://dx.doi.org/10.1111/1759-7714.14149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8563146/
https://www.ncbi.nlm.nih.gov/pubmed/34523232
http://dx.doi.org/10.1111/1759-7714.14149

Ejemplares similares